Feasibility Study of a New Peripheral Oedema Monitor for Heart Failure

NCT02993601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2021-10-13

No results posted yet for this study

Summary

The study aims at assessing the usefulness of the Heartfelt1 device in patients suffering from heart failure, who have peripheral oedema. The device is non-contact and does not requires patient compliance to work. It gives an output reading of the patient's lower leg volume.

During the study, this measurement will be compared to clinical standard and gold standard measurements as well as clinical grading of peripheral oedema.

Conditions

  • Heart Failure, Diastolic
  • Edema Brain
  • Decompensated Heartfailure

Interventions

DEVICE

Heartfelt-1

The patients will stand in front of the Heartfelt-1 in order for images to be captured and the volume of their lower legs measured.

DEVICE

Weighing scales

The patient will be asked to stand on standard medical weighing scales, to measure their weight.

OTHER

Medical grading of oedema

A member of the research team will assess the severity of the peripheral oedema on a scale of 1-5.

OTHER

Baseline assessements

At the point study participants are recruited, their age, sex, diagnosis, aetiology of heart failure, LVEF (Left ventricular ejection fraction), medical and device therapy, time since diagnosis, BNP (B-type Natriuretic Peptide), CRP (C-Reactive Protein), renal function (EGFR), Haemoglobin, albumin and urinalysis will be assessed unless recent (less that 6 months old) results are available. The number of Heart failure hospital admissions in the last 2 years, LACE score, co-morbidities will also be noted.

DEVICE

Water displacement method

This will involve filling a gauge with lukewarm water (27-35oC +-2oC) up to the appropriate level. The appropriate level is determined by the water stabilising after some has flown out of the gauge into the waste bucket. Once the water level is stable the patient, who is sitting on a chair will be gently plunging the foot (naked) in the gauge until their foot is flat on the bottom on the gauge. The water flowing out of the gauge into the measuring bucket will be collected until the flow of water stops. Four small marks with non-toxic /non-permanent pen will be made on the lower leg of the patient to indicate where the water level was at. The water which has been collected in the measuring bucket will be weighted with precision scales to determine the volume of water displaced by the insertion of the foot. The patient's foot will then be dried.

DEVICE

Callipers measurements

This will involve making 4 marks on one of the foot/lower leg (small cross) using non-toxic / non- permanent pen. The measurement will consist of making 6 measurements between those marks using callipers, and reporting the distance on a calibrated tape.

DEVICE

Measuring tape

The measurements taken using a medical tape measure will involve the circumference of the ankle to be measured as well as the circumference at the level of the arch of the foot. The medical tape used will be a CE marked disposable medical measuring tape to minimise the risk of infection. The measurements will be done on both feet.

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER
  • Heartfelt Technologies

    lead INDUSTRY

Principal Investigators

  • Alexander Lyon, BCh PhD FRCP · Royal Brompton and Harefield NHS Foundation Trust

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-15
Primary Completion
2017-06-13
Completion
2017-06-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02993601 on ClinicalTrials.gov